Rheumatology

Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…

Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…

Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…

The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…

Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…

This article presents a case of infection after ACL reconstruction and discusses risk factors, treatment choice, antibiotic treatment length, and functional outcomes, proposing a guide for the treatment.

The aim of this review is to illustrate the role of NAD+-related enzymes in the pathogenesis of RA and highlight the potential therapeutic role of NAD+ in RA.